rs200250181

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020822.3(KCNT1):​c.3239G>T​(p.Gly1080Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0025 in 1,610,928 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G1080G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0015 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 8 hom. )

Consequence

KCNT1
NM_020822.3 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.55

Publications

0 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059975684).
BP6
Variant 9-135786258-G-T is Benign according to our data. Variant chr9-135786258-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 385356.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00152 (231/152120) while in subpopulation NFE AF = 0.00255 (173/67932). AF 95% confidence interval is 0.00224. There are 2 homozygotes in GnomAd4. There are 93 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 231 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.3239G>Tp.Gly1080Val
missense
Exon 29 of 31NP_065873.2Q5JUK3-3
KCNT1
NM_001272003.2
c.3104G>Tp.Gly1035Val
missense
Exon 28 of 31NP_001258932.1Q5JUK3-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.3239G>Tp.Gly1080Val
missense
Exon 29 of 31ENSP00000360822.2Q5JUK3-3
KCNT1
ENST00000460750.5
TSL:1
n.*2849G>T
non_coding_transcript_exon
Exon 29 of 32ENSP00000418777.1F8WC49
KCNT1
ENST00000460750.5
TSL:1
n.*2849G>T
3_prime_UTR
Exon 29 of 32ENSP00000418777.1F8WC49

Frequencies

GnomAD3 genomes
AF:
0.00152
AC:
231
AN:
152006
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.000754
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00255
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00186
AC:
434
AN:
233102
AF XY:
0.00195
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000412
Gnomad ASJ exome
AF:
0.00470
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000238
Gnomad NFE exome
AF:
0.00309
Gnomad OTH exome
AF:
0.00174
GnomAD4 exome
AF:
0.00260
AC:
3799
AN:
1458808
Hom.:
8
Cov.:
36
AF XY:
0.00255
AC XY:
1849
AN XY:
725654
show subpopulations
African (AFR)
AF:
0.000419
AC:
14
AN:
33448
American (AMR)
AF:
0.000314
AC:
14
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.00326
AC:
85
AN:
26064
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39642
South Asian (SAS)
AF:
0.00156
AC:
134
AN:
86010
European-Finnish (FIN)
AF:
0.000542
AC:
28
AN:
51694
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5752
European-Non Finnish (NFE)
AF:
0.00306
AC:
3404
AN:
1111376
Other (OTH)
AF:
0.00188
AC:
113
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
229
457
686
914
1143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
231
AN:
152120
Hom.:
2
Cov.:
33
AF XY:
0.00125
AC XY:
93
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.000506
AC:
21
AN:
41520
American (AMR)
AF:
0.000719
AC:
11
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4814
European-Finnish (FIN)
AF:
0.000754
AC:
8
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00255
AC:
173
AN:
67932
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00217
Hom.:
1
Bravo
AF:
0.00159
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000241
AC:
1
ESP6500EA
AF:
0.00222
AC:
18
ExAC
AF:
0.00187
AC:
223
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00262
EpiControl
AF:
0.00149

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Developmental and epileptic encephalopathy, 14 (1)
-
-
1
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
KCNT1-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
17
DANN
Benign
0.60
DEOGEN2
Benign
0.058
T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.89
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.91
D
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.6
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-2.5
N
REVEL
Benign
0.045
Sift
Uncertain
0.010
D
Sift4G
Benign
0.33
T
Vest4
0.20
MVP
0.35
MPC
0.11
ClinPred
0.031
T
GERP RS
0.83
Varity_R
0.11
gMVP
0.49
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200250181; hg19: chr9-138678104; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.